Human Milk Oligosaccharides Market Size, Share, Growth Report 2030

The global Human Milk Oligosaccharides market value was estimated at 7.69 (USD Billion) in 2019 and is projected to register a CAGR of nearly 15.1% during the period from 2019 to 2025. The market is projected to accrue earnings worth 22.59 (USD Billion) by 2025. The report offers valuation and analysis of the Human Milk Oligosaccharides market on a global as well as regional level. The study offers a comprehensive assessment of the industry competition, restraints, revenue estimates, avenues, current & emerging trends, and industry-validated market information. The report offers historical data from 2016 to 2018 along with a forecast from 2019 to 2025 based on value (USD Billion).

Request Free Sample

Introduction

Human milk oligosaccharides are available in breast milk and it finds key application in infant formulas and pharmacology. In addition to this, breast milk offers a balanced nutrient for infant & comprises large proportion of bio-active ingredients including immunoglobulin, oligosaccharides, and hormones. HMOs also referred as human milk oligosaccharides are one of the key component of human milk. Reportedly, these products are structurally & biologically myriad groups of non-digestible sugars having complex structure. The product possesses anti-adhesive features and helps in reducing the infection risk from protozoa, virus, and bacteria.

Market Growth Drivers

The ability of the breast milk in protecting infants from infection along with shielding them from allergic reactions will steer the market size. Apparently, human milk oligosaccharides offers protection to human beings for long-term, namely, against obesity, high blood pressure, auto-immune disorders, diabetes, and heart disorders. Additionally, the compound inhibits sticking of microbes to intestines, proliferation of pathogens & organic acids, and helps in reducing inflammation, thereby driving market trends. The product helps in maintaining gut health through raising the production short-chain fatty acids – a key energy source for enterocytes & main molecule for gut health maintenance.

Apparently, surge in the application of the product in infant formula as well as functional beverages and addition to the product line will prompt the scope of the human milk oligosaccharides market in the years ahead. Growing concerns pertaining to malnourishment in children and rise in the infant mortality rate has culminated in product penetration across the global healthcare sector.

Report Scope:

North American Market Size To Expand Manifold Over 2019-2025

The expansion of the human milk oligosaccharides market in the sub-continent over the assessment period is due to massive demand for human donor milk for infants. Reportedly, there are nearly eleven milk banks in the U.S. and Canada. However, these are unable to fulfill the growing demand for breast milk for infants in the sub-continent, thereby steering the market growth in the region. Surge in the consumer awareness pertaining to health benefits of the human milk oligosaccharides for infants will prompt the regional industry growth over the assessment period.

Key participants profiled in the study are Elicityl SA, Inbiose, Medolac Laboratories, ZuChem, Inc., Jennewein Biotechnologie GmbH, Glycom A/S, and Glycosyn LLC.

The global human milk oligosaccharides market is segmented as follows:

By Type

• 2’FL
• 3’FL
• 3’SL
• 6’SL

By Application

• Infant formulas
• Health ingredients for human and animal
• Food & beverages
• Food supplements

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa